Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis.
about
Recommendations for the radiological diagnosis and follow-up of neuropathological abnormalities associated with tuberous sclerosis complex.Retraction: Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis.Topical rapamycin (sirolimus) for facial angiofibromas.Rapamycin therapy for neonatal tuberous sclerosis complex with cardiac rhabdomyomas: A case report and review.
P2860
Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis.
@ast
Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis.
@en
type
label
Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis.
@ast
Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis.
@en
prefLabel
Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis.
@ast
Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis.
@en
P2860
P1476
Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis.
@en
P2093
Won Seop Kim
P2860
P304
P356
10.3345/KJP.2011.54.6.241
P577
2011-06-30T00:00:00Z